Mostrar el registro sencillo del ítem

24-month decline of non-invasive liver fibrosis markers in hcv-mono and hcv/hiv coinfection after direct-acting antiviral therapy

dc.contributor.authorPérez Is, Laura 
dc.contributor.authorCollazos, J.
dc.contributor.authorde la Fuente, B.
dc.contributor.authorMorano, L.
dc.contributor.authorRivas Carmenado, M.
dc.contributor.authorRodríguez, M.
dc.contributor.authorRomero Favela, A.
dc.contributor.authorFonseca González, G. J.
dc.contributor.authorMelón S.
dc.contributor.authorValle Garay, Eulalia 
dc.contributor.authorAsensi Álvarez, Víctor 
dc.date.accessioned2022-10-25T11:11:05Z
dc.date.available2022-10-25T11:11:05Z
dc.date.issued2022
dc.identifier.citationScientific Reports, 12(1) (2022); doi:10.1038/s41598-022-07548-y
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/10651/65214
dc.description.sponsorshipThis study was funded with the Fondo de Investigaciones Sanitarias grant FIS (FISS-17- PI16/01999) and a research grant from VIIV Healthcare Spain given to Víctor Asensi.
dc.language.isoeng
dc.relation.ispartofScientific Reports
dc.rights© The Author(s) 2022.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85126077541&doi=10.1038%2fs41598-022-07548-y&partnerID=40&md5=b5ae63089d484dad09785c6f666a8ec4
dc.title24-month decline of non-invasive liver fibrosis markers in hcv-mono and hcv/hiv coinfection after direct-acting antiviral therapy
dc.typejournal article
dc.identifier.doi10.1038/s41598-022-07548-y
dc.relation.projectIDFISS-17- PI16/01999
dc.relation.publisherversionhttp://dx.doi.org/10.1038/s41598-022-07548-y
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© The Author(s) 2022.
Este ítem está sujeto a una licencia Creative Commons